Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$127M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Hager Alicia J. | Jul 16, 2024 | Sell | 3,396 | $8 | $27,000 |
| HASTINGS PAUL J | Jun 18, 2024 | Sell | 1,770 | $5.6 | $9,900 |
| Trager James | Jun 18, 2024 | Sell | 456 | $5.6 | $2,600 |
| Shook David | Jun 18, 2024 | Sell | 456 | $5.6 | $2,600 |
| Hager Alicia J. | Jun 18, 2024 | Sell | 727 | $5.6 | $4,100 |
| Brandenberger Ralph | Jun 18, 2024 | Sell | 229 | $5.6 | $1,300 |
| RA Capital Healthcare Fund LP | Mar 27, 2024 | Buy | 3,000,031 | $9.9999 | $30M |
| RA Capital Healthcare Fund LP | Mar 27, 2024 | Buy | 3,000,000 | $10 | $30M |
| George Simeon | Mar 27, 2024 | Buy | 1,548,341 | $10 | $15M |
| George Simeon | Mar 27, 2024 | Buy | 451,659 | $10 | $4.5M |
| Brandenberger Ralph | Mar 1, 2024 | Sell | 8,367 | $12.51 | $100,000 |
| Trager James | Feb 12, 2024 | Sell | 4,143 | $12 | $50,000 |
| Shook David | Jan 16, 2024 | Sell | 3,552 | $8.74 | $31,000 |
| Trager James | Jan 16, 2024 | Sell | 4,560 | $8.74 | $40,000 |
| Brandenberger Ralph | Jan 16, 2024 | Sell | 2,512 | $8.74 | $22,000 |
| HASTINGS PAUL J | Jan 16, 2024 | Sell | 9,697 | $8.74 | $85,000 |
| Hager Alicia J. | Jan 16, 2024 | Sell | 4,554 | $8.74 | $40,000 |
| Shook David | Aug 21, 2023 | Sell | 1,331 | $1.83 | $2,400 |
| HASTINGS PAUL J | Jun 20, 2023 | Sell | 1,704 | $4.85 | $8,300 |
| Trager James | Jun 20, 2023 | Sell | 439 | $4.85 | $2,100 |
| Brandenberger Ralph | Jun 20, 2023 | Sell | 221 | $4.85 | $1,100 |
| Hager Alicia J. | Jun 20, 2023 | Sell | 701 | $4.85 | $3,400 |
| Shook David | Jun 20, 2023 | Sell | 439 | $4.85 | $2,100 |
| Mahmood Nadir | Jun 20, 2023 | Sell | 526 | $4.85 | $2,600 |
| Trager James | Jan 17, 2023 | Sell | 1,115 | $5.49 | $6,100 |
| Mahmood Nadir | Jan 17, 2023 | Sell | 1,122 | $5.49 | $6,200 |
| HASTINGS PAUL J | Jan 17, 2023 | Sell | 3,691 | $5.49 | $20,000 |
| Hager Alicia J. | Jan 17, 2023 | Sell | 1,103 | $5.49 | $6,100 |
| Shook David | Jan 17, 2023 | Sell | 175 | $5.49 | $960 |
| Brandenberger Ralph | Jan 17, 2023 | Sell | 491 | $5.49 | $2,700 |
| Brandenberger Ralph | Oct 6, 2022 | Sell | 842 | $14.02 | $12,000 |
| HASTINGS PAUL J | Sep 29, 2022 | Sell | 498 | $13 | $6,500 |
| HASTINGS PAUL J | Sep 28, 2022 | Sell | 23,376 | $13.0311 | $300,000 |
| HASTINGS PAUL J | Sep 21, 2022 | Sell | 6,126 | $13.0129 | $80,000 |
What's the latest insider transaction for Nkarta?
The most recent insider transaction for Nkarta was conducted by Hager Alicia J., who sold 3,396 shares on July 16, 2024 at a price of $8.00 per share.
Which insider bought the most NKTX stock over the last two years?
RA Capital Healthcare Fund LP has bought the most NKTX stock in the last 2 years, with a total value of $60M.
Which insider has sold the most NKTX stock over the last two years?
HASTINGS PAUL J has sold the most NKTX stock in the last 2 years, with a total value of $510,000.
What is the total value of insider transactions for Nkarta (NKTX) in the last 2 years?
According to our estimates, the total value of insider transactions for Nkarta in the last 2 years is positive, amounting to $79M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Nkarta's market confidence?
Over the last 2 years, insider transactions for Nkarta have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.